We are live on ! Find out more
CC

CQS Cayman Portfolio holdings

AUM $2.26B
1-Year Est. Return 1.31%
This Fund
S&P 500
This Quarter Est. Return
+5.65%
1 Year Est. Return
+1.31%
3 Year Est. Return
+15.29%
5 Year Est. Return
+28.07%
10 Year Est. Return
AUM
$1.5B
AUM Growth
-$181M
Cap. Flow
-$511M
Cap. Flow %
-33.98%
Top 10 Hldgs %
46.93%
Holding
204
New
51
Increased
33
Reduced
24
Closed
49

Sector Composition

Rank Sector Weight
1 Communication Services 14.83%
2 Healthcare 7.02%
3 Financials 4.74%
4 Consumer Discretionary 4.35%
5 Energy 2.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
F icon
26
PUT
Ford
F
$56.9B
$9.3M 0.62%
600,000
IONS icon
27
Ionis Pharmaceuticals
IONS
$9.32B
$9.26M 0.62%
150,000
KITE
28
DELISTED
Kite Pharma, Inc.
KITE
$8.36M 0.56%
+145,000
New +$6.1M
TSM icon
29
TSMC
TSM
$2.09T
$8.3M 0.55%
371,044
-6,711
-2% -$146K
ARIA
30
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$8.24M 0.55%
1,200,000
+100,000
+9% +$625K
SNDK
31
DELISTED
SANDISK CORP
SNDK
$7.44M 0.5%
75,974
+15,796
+26% +$1.51M
MRO
32
DELISTED
Marathon Oil Corporation
MRO
$7.4M 0.49%
261,688
+30,139
+13% +$959K
INCY icon
33
Incyte
INCY
$23.5B
$7.31M 0.49%
100,000
-35,000
-26% -$2.29M
MRVL icon
34
CALL
Marvell Technology
MRVL
$174B
$7.25M 0.48%
500,000
FCX icon
35
Freeport-McMoran
FCX
$89.5B
$7.09M 0.47%
303,400
+198,298
+189% +$5.47M
RPRX
36
DELISTED
Repros Therapeutics Inc.
RPRX
$6.98M 0.46%
700,000
+150,000
+27% +$1.28M
F icon
37
Ford
F
$56.9B
$6.95M 0.46%
448,300
+258,000
+136% +$3.8M
BMRN icon
38
BioMarin Pharmaceuticals
BMRN
$11.4B
$6.78M 0.45%
75,000
-10,000
-12% -$832K
ALXN
39
DELISTED
Alexion Pharmaceuticals
ALXN
$6.71M 0.45%
+36,286
New +$6.72M
ROC
40
DELISTED
ROCKWOOD HLDGS INC
ROC
$6.57M 0.44%
83,400
-32,603
-28% -$2.51M
TWC
41
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$6.34M 0.42%
41,724
-16,961
-29% -$2.45M
HCBK
42
DELISTED
HUDSON CITY BANCORP INC
HCBK
$6.22M 0.41%
615,152
-295,426
-32% -$2.85M
NPSP
43
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$6.08M 0.4%
170,000
PBR.A icon
44
Petrobras Class A
PBR.A
$107B
$5.91M 0.39%
+779,659
New +$8.8M
CLVS
45
DELISTED
Clovis Oncology, Inc.
CLVS
$5.88M 0.39%
105,000
-20,000
-16% -$1.05M
FCX icon
46
PUT
Freeport-McMoran
FCX
$89.5B
$5.84M 0.39%
250,000
HUN icon
47
PUT
Huntsman Corp
HUN
$2.26B
$5.7M 0.38%
250,000
AGN
48
DELISTED
Allergan Inc
AGN
$5.53M 0.37%
+26,000
New +$5.17M
TX icon
49
Ternium
TX
$9.29B
$5.52M 0.37%
312,969
+125,900
+67% +$2.53M
DRC
50
DELISTED
DRESSER-RAND GROUP INC
DRC
$5.5M 0.37%
+67,300
New +$5.48M

Similar funds

CQS Cayman's Q4 2014 Portfolio in Review

As of Q4 2014, CQS Cayman held 204 positions worth $1.5B, down 11% from $1.68B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

CQS Cayman withdrew a net $511M in Q4 2014, closing 49 positions and reducing 24 holdings. Its most notable exit was FOSTER WHEELER AG (SWITZERLAND), an estimated $30M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, CQS Cayman opened a new position in Stellantis worth $31.6M.

  • CQS Cayman's largest Q4 2014 buy was Stellantis: 4,182,178 shares worth $31.6M.
  • CQS Cayman added most to MGM Resorts International in Q4 2014, an estimated $10.2M increase.
  • CQS Cayman's biggest Q4 2014 reduction was Citigroup, cutting an estimated $10.6M.
  • CQS Cayman fully exited FOSTER WHEELER AG (SWITZERLAND) in Q4 2014, selling an estimated $30M.
  • CQS Cayman's ten largest holdings make up 47% of its $1.5B portfolio in Q4 2014.
  • CQS Cayman opened 51 new positions and closed 49 in Q4 2014.
  • CQS Cayman's portfolio value fell 11% quarter-over-quarter to $1.5B.

Based on CQS Cayman's 13F filing for Q4 2014, filed 13 Feb 2015.